5th RNA Editing Summit 2024

R&D

Pioneering RNA Editing Drugs Towards Clinical Realities

Scheduled for June 2024, the 5th RNA Editing Summit is set to spotlight brand-new advances towards the clinic and strategies for targeting beyond the liver. With an expert speaker faculty, including companies such as AIRNA, Amber Bio, Radar Therapeutics, Splice Therapeutics and more, explore the latest breakthroughs in ADAR editing, RNA trans-splicing, gRNA-free editing, and RADAR technology.

Join leading companies; Wave Life Sciences, ProQR Therapeutics, Korro Bio, Shape Therapeutics, EdiGene, and more for 3-days showcasing data-driven presentations and interactive discussions, propelling RNA editing therapeutics through the clinic and toward regulatory approval.

Don't miss this opportunity to be at the forefront of RNA editing innovation. Secure your spot at the 5th RNA Editing Summit today!

Snapshot of Expert Speakers:

Cynthia Caracta, Executive Medical Director, Wave Life Sciences
Jacob Borrajo, Co-Founder & Chief Executive Officer, Amber Bio
Kris Elverum, Chief Executive Officer, AIRNA
Lina Bagepalli, Scientist II, Shape Therapeutics
Pengfei Yuan, Chief Technology Officer, EdiGene
Venkat Krishnamurthy, Senior Vice President, Head Of Platform & RNA Editing, Korro Bio